360 related articles for article (PubMed ID: 24934774)
1. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
Henney HR; Sperling MR; Rabinowicz AL; Bream G; Carrazana EJ
Epilepsy Res; 2014 Sep; 108(7):1204-11. PubMed ID: 24934774
[TBL] [Abstract][Full Text] [Related]
2. A pilot study assessing the bioavailability and pharmacokinetics of diazepam after intranasal and intravenous administration in healthy volunteers.
Agarwal SK; Kriel RL; Brundage RC; Ivaturi VD; Cloyd JC
Epilepsy Res; 2013 Aug; 105(3):362-7. PubMed ID: 23561287
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of intranasal vs. rectal diazepam.
Ivaturi V; Kriel R; Brundage R; Loewen G; Mansbach H; Cloyd J
Epilepsy Res; 2013 Feb; 103(2-3):254-61. PubMed ID: 22981338
[TBL] [Abstract][Full Text] [Related]
4. Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy.
Sperling MR; Haas KF; Krauss G; Seif Eddeine H; Henney HR; Rabinowicz AL; Bream G; Squillacote D; Carrazana EJ
Epilepsia; 2014 Oct; 55(10):1544-50. PubMed ID: 25154625
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and tolerability of intranasal diazepam in healthy adult volunteers.
Ivaturi VD; Riss JR; Kriel RL; Siegel RA; Cloyd JC
Epilepsy Res; 2009 Apr; 84(2-3):120-6. PubMed ID: 19231138
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL-1 to Healthy Volunteers.
Tanimoto S; Pesco Koplowitz L; Lowenthal RE; Koplowitz B; Rabinowicz AL; Carrazana E
Clin Pharmacol Drug Dev; 2020 Aug; 9(6):719-727. PubMed ID: 31916704
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study.
Lamson MJ; Sitki-Green D; Wannarka GL; Mesa M; Andrews P; Pellock J
Clin Drug Investig; 2011; 31(8):585-597. PubMed ID: 21721594
[TBL] [Abstract][Full Text] [Related]
8. Diazepam autoinjector intramuscular delivery system versus diazepam rectal gel: A pharmacokinetic comparison.
Garnett WR; Barr WH; Edinboro LE; Karnes HT; Mesa M; Wannarka GL
Epilepsy Res; 2011 Jan; 93(1):11-6. PubMed ID: 21145707
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers.
Hogan RE; Gidal BE; Koplowitz B; Koplowitz LP; Lowenthal RE; Carrazana E
Epilepsia; 2020 Mar; 61(3):455-464. PubMed ID: 32065672
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters.
Cloyd J; Haut S; Carrazana E; Rabinowicz AL
Epilepsia; 2021 Apr; 62(4):846-856. PubMed ID: 33617690
[TBL] [Abstract][Full Text] [Related]
12. A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.
Albrecht D; Iwashima M; Dillon D; Harris S; Levy J
Headache; 2020 Apr; 60(4):701-712. PubMed ID: 31985049
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.
Bancke LL; Dworak HA; Rodvold KA; Halvorsen MB; Gidal BE
Epilepsia; 2015 Nov; 56(11):1723-31. PubMed ID: 26332539
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tolerability of nasal versus intravenous midazolam in healthy Dutch volunteers: a single-dose, randomized-sequence, open-label, 2-period crossover pilot study.
Veldhorst-Janssen NM; Fiddelers AA; van der Kuy PH; Theunissen HM; de Krom MC; Neef C; Marcus MA
Clin Ther; 2011 Dec; 33(12):2022-8. PubMed ID: 22078155
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tolerability of intranasal diazepam and midazolam in healthy adult volunteers.
Ivaturi VD; Riss JR; Kriel RL; Cloyd JC
Acta Neurol Scand; 2009 Nov; 120(5):353-7. PubMed ID: 19456308
[TBL] [Abstract][Full Text] [Related]
16. Absorption of diazepam after its rectal administration in dogs.
Papich MG; Alcorn J
Am J Vet Res; 1995 Dec; 56(12):1629-36. PubMed ID: 8599525
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations.
Patel P; Salapatek AM; Talluri RS; Tantry SK
Allergy Asthma Proc; 2018 May; 39(3):224-231. PubMed ID: 29669667
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
[TBL] [Abstract][Full Text] [Related]
19. Diazepam pharmacokinetics after nasal drop and atomized nasal administration in dogs.
Musulin SE; Mariani CL; Papich MG
J Vet Pharmacol Ther; 2011 Feb; 34(1):17-24. PubMed ID: 21219339
[TBL] [Abstract][Full Text] [Related]
20. STOP 101: A Phase 1, Randomized, Open-Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD
Shrewsbury SB; Jeleva M; Satterly KH; Lickliter J; Hoekman J
Headache; 2019 Mar; 59(3):394-409. PubMed ID: 30659611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
